The development of guidelines for the treatment of vitiligo

Archives of Dermatology

Volumn 135, Issue 12, 1999, Pages 1514-1521

  Njoo, M D ^a,b   Westerhof, W ^a   Bos, J D ^a   Bossuyt, P M M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ARTICLE; HUMAN; LASER SURGERY; MEDICAL DECISION MAKING; PHOTOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SKIN TRANSPLANTATION; TREATMENT INDICATION; TREATMENT PLANNING; VITILIGO;

EID: 0032763422     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.135.12.1514     Document Type: Article

References (23)

1. Nordlund JJ, Ortonne JP. Vitiligo vulgaris. In: Nordlund JJ, Boissy RE, Hearing VJ, King RA, Ortonne JP, eds. The Pigmentary System: Physiology and Pathophysiology. New York. NY: Oxford University Press; 1998:513-551.
2. Woolf SH. Practice guidelines: a new reality in medicine, I: recent developments. Arch Intern Med. 1990;150:1811-1818.
3. Woolf SH. Practice guidelines, a new reality in medicine, II: methods of developing guidelines. Arch Intern Med. 1992;152:946-952.
4. Woolf SH. Practice guidelines: a new reality in medicine, III: impact on patient care. Arch Intern Med. 1993;153:2646-2655.
5. Kenney JA Jr, Grimes PE. How we treat vitiligo. Cutis. 1983;32:347-348.
6. Antoniou C, Katsambas A. Guidelines for the treatment of vitiligo. Drugs. 1992; 43:490-498.
7. Grimes PE. Vitiligo: an overview of therapeutic approaches. Dermatol Clin. 1993; 11:325-338.
8. Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for vitiligo: American Academy of Dermatology. J Am Acad Dermatol. 1996;35:620-626.
9. Eddy DM. The challenge. JAMA. 1990;263:287-290.
10. Evidence-Based Medicine Working Group. Evidence-based medicine: a new approach to teaching the practice of medicine. JAMA. 1992;268:2420-2425.
11. Sackett DL, Rosenberg WM, Gray JAM, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ. 1996;312:71-72.
12. Ladhani S. The need for evidence-based management of skin diseases. Int J Dermatol. 1997;36:17-22.
13. Eddy DM. Clinical decision making: from theory to practice: guidelines for policy statements: the explicit approach. JAMA. 1990;263:2239-2240, 2243.
14. Njoo MD, Spuls PI, Bos JD, Westerhof W, Bossuyt PMM. Nonsurgical repigmentation therapies in vitiligo: meta-analysis of the literature. Arch Dermatol. 1998;134:1532-1540.
15. Njoo MD, Westerhof W, Bos JD, Bossuyt PMM. A systematic review of autologous transplantation methods in vitiligo. Arch Dermatol. 1998;134:1543-1549.
16. Mosher DB, Parrish JA, Fitzpatrick TB. Monobenzylether of hydroquinone: a retrospective study of treatment of 18 vitiligo patients and a review of the literature. Br J Dermatol. 1977;97:669-679.
17. Thissen M, Westerhof W. Laser treatment for further depigmentation in vitiligo. Int J Dermatol. 1997;36:386-388.
18. Westerhof W, Nieuweboer-Krobotova L, Mulder PG, Glazenburg EJ. Left-right comparison study of the combination of fluticasone propionate and UV-A vs either fluticasone propionate and UV-A alone for the long-term treatment of vitiligo. Arch Dermatol. 1999;135:1061-1066.
19. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet. 1993;342:1317-1322.
20. Grimshaw JM, Russell IT. Achieving health gain through clinical guidelines, I: developing scientifically valid guidelines. Qual Health Care. 1993;2:243-248.
21. Grimshaw JM, Russell IT. Achieving health gain through clinical guidelines, II: ensuring guidelines change medical practice. Qual Health Care. 1994;3:45-52.
22. Eddy DM. Clinical decision making: from theory to practice: practice policies -what are they? JAMA. 1990;263:877-880.
23. Zug KA, Littenberg B, Baughman RD, et al. Assessing the preference of patients with psoriasis: a quantitative, utility approach. Arch Dermatol. 1995;131: 561-568.